Price movement over the last 24 hours
Agilent Technologies Inc vs ARK Autonomous Technology & Robotics ETF — how do they compare? Agilent Technologies Inc trades at $129 (market cap $37.04B), while ARK Autonomous Technology & Robotics ETF trades at $123.06. The key difference: Agilent Technologies Inc pays a 0.78% dividend while ARK Autonomous Technology & Robotics ETF pays none, and ARK Autonomous Technology & Robotics ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | ARKQ | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Sector/Thematic |
52-Week High | $157.20 | $143.82 |
52-Week Low | $110.24 | $88.47 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
ARKQ trades at $130.11, up 1.7% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF focuses on autonomous technology and robotics, benefiting from AI momentum, with assets under management reaching $2.7 billion as of April 2026 (Seeking Alpha, 2026-04-26). Recent news highlights sector growth in AI, robotics, and autonomous vehicles, though valuation metrics like P/E are not provided in the current data.
Outlook remains tied to AI and robotics adoption, with potential from themes like humanoid robots and autonomous driving. Risks include high valuations, sector volatility, and reliance on tech spending. Analyst sentiment is mixed, with some upgrades citing growth potential but technical indicators suggesting near-term caution.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.
Read more on ARKQ →